Innovating Works
PRIME: Prevention and Remediation of Insulin Multimorbidity in Europe GESTAMP VIGO, S.A. participó en un H2020: H2020-SC1-BHC-2018-2020 PRIME introduces the novel concept of insulin signalling as a key mechanism underlying the multimorbidity of major mental and somatic illnes...
2019-12-06 - 2024-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.